MedWatch

ALK execs sell shares worth USD 4m

The CEO and CFO at ALK have sold shares in the allergy firm for DKK 26.5m (USD 4m).

Photo: ALK / PR

Allergy firm ALK's CEO, Carsten Hellmann, and CFO, Søren Jelert, have sold shares worth DKK 26.5m (USD 4m), a company announcement states.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs